Acute Coronary Syndromes
Scorecard-rated PCI operators in New York found to steer clear of MI-related shock
January 25, 2008 | Steve Stiles

Albany, NY - Concerned about going from notable to notorious when their names are published alongside their procedure-related mortality figures, New York PCI practitioners are less willing to treat patients with MI-related shock than their counterparts in states without such public reporting of operator-specific outcomes [1]. So conclude the authors of a retrospective analysis of US patients in the SHOCK registry appearing in the February 2008 issue of the American Heart Journal.

Although New York's Cardiac Surgery and Percutaneous Coronary Intervention Reporting System was designed largely to improve quality of care, the group observes, "There is evidence that for some patient cohorts it may do the opposite." One possibility from the data is that the reporting system makes revascularization more likely for the "healthier" patients with MI-related shock than for those who appear higher risk, according to the authors, led by Dr Renato A Apolito (New York University School of Medicine, NY).

This is a very real concern and would certainly be an unintended consequence of reporting and something that we need to track and understand.

"We posit that this is likely due to concern among interventionalists that the high mortality associated with cardiogenic shock would negatively impact their standing in New York's public report," they write. The conclusion is consistent with a number of other studies, some reported by heartwire [2,3], that have suggested New York's reporting system discourages operators from accepting all the cases they would otherwise take.

Dr Harlan M Krumholz (Yale University, New Haven, CT), who wasn't connected with the SHOCK analysis, agrees that it is, in fact, one of a growing number of studies questioning whether public reporting might be restricting healthcare access for some patients whom physicians believe will be a drag on their report-card standings.

"This is a very real concern and would certainly be an unintended consequence of reporting and something that we need to track and understand," Krumholz told heartwire. "It would be unfortunate if any physicians put concerns about their own ratings ahead patient interest, but it's natural for people to pause in taking patients who look like they are very high risk to the lab when they think there may be little chance of survival."

Apolito et al say their study is the first to explore the phenomenon specifically in patients with MI-related shock. What the analysis may indicate, Krumholz proposes, is a lack of trust that the reporting system's risk-adjusted outcomes figures truly account for the higher risk of patients in shock.

I think we're still in the early phases of public-reporting systems, and we need to work hard to prevent unintended consequences.

The analysis compared the registry's 325 patients treated in states without public reporting systems with the 220 New York patients, who were significantly less likely—after adjustment for propensity scores based on a long list of demographic, clinical, and laboratory risk factors—to undergo diagnostic angiography (odds ratio 0.46; 95% CI 0.31-0.68; p<0.001) or PCI (OR 0.51; 95% CI 0.33-0.77; p=0.002). There was no such significant difference for CABG. However, among those getting the surgery, 75.5% of non-New York patients but only 32.3% of New York patients (p<0.001) had it within three days of shock onset.

The adjusted risk of in-hospital death for New York patients vs non-New York patients was increased by 50% overall (OR 1.50; 95% CI 1.01-2.21; p=0.04) and more than doubled among those not getting either PCI or CABG (OR 2.12; 95% CI 1.20-3.75; p=0.01) but wasn't significantly different among those who were revascularized (OR 0.73; 95% CI 0.40-1.32; p=0.30).

"I think we're still in the early phases of public-reporting systems, and we need to work hard to prevent unintended consequences," Krumholz said. "This study isn't definitive, and we still don't really know whether public reporting has led to people who might have benefited from the procedures being turned away, but I think it speaks to the need for us to develop the means to track it and figure out how best to avoid it."

Sources
  1. Apolito RA, Greenberg MA, Menegus MA, et al. Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock. Am Heart J 2008; 155:267-273.
  2. Narins CR, Dozier AM, Ling FS, et al. The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med 2005; 165:83-87.
  3. Moscucci M, Eagle KA, Share D, et al. Public reporting and case selection for percutaneous coronary interventions. J Am Coll Cardiol 2005; 45:1759-1765.



Your comments
Scorecard-rated PCI operators in New York found to steer clear of MI-related shock
# 1 of 6
January 28, 2008 10:45 (EST)
michael fischi
Nothing shocking about this news :)
Those of us who practice in NYS often gripe about this issue. Patients seeking an interventional cardiologist with the lowest mortality rates published in the newspapers may only succeed in choosing a Dr. who'll walk away when they need them the most.

I shouldn't have the fear of a NYS issued demerit discourage me from trying to save a dying patient.


# 2 of 6
January 29, 2008 07:04 (EST)
Melissa Walton-Shirley
Truly a pathetic approach to AMI care
Michael, so true.
Here in Kentucky, we are still "piloting" primary PCI without surgical back up for AMI.
I CANNOT imagine going to the ER and saying "we can't take this shocky patient to the lab with 10mm ST elevation because it might make our stats look bad, let's put him in a helicopter or in an ambulance and transfer this patient with no BP to another hospital for surgery so we can still look good".
We were put into an impossible position being told that we can do AMI but we can't do non urgents (I take issue with the term elective, someone with progressive chest pain and detectable troponin, though not ST elevated is NOT elective). So, OUR stats include ONLY patients who ARE ST elevated, sometimes SHOCKY and sometimes Imminently dying. We've broken out the balloon pump several times in the last three years.
The patients can look at any number of scorecards they wish, but our PCI program is the only game in town and if they want to live.......they have to get in the game from our ER guerny and they are grateful to do it.
This entire story is a very pompous look at the sharp divide between acute metropolitan AMI care and rural AMI care. Beggars can't be choosers but at the same time, we need to make certain we are delivering the best possible care to those who have no choice. What about the legalities of forcing transfer from a non PCI hospital to a PCI hospital where cath is done, then delay to the OR instead of just doing the vessel?
And who are these surgeons who are taking the patient to the OR with no BP? Are you running out of IABP's? Isn't taking the "fresh" MI to the OR going to result in increased CABG mortality ? I guess they are so desparate for numbers that they don't care?
Sounds like the score-card program is better for PCI stats, worse for CABG stats and ultimately worse for patients.
Pah-leese.
Melissa
# 3 of 6
January 29, 2008 09:13 (EST)
David Cohen
Not quite
Melissa-
I think you may have missed the point. The NY state surgeons aren't taking the AMI/Shock patients to the OR any more than the PCI operators. They are under the same exact scorecarding/benchmarking pressures (and have been this way for longer than the PCI operators). The issue is that no one is taking these high mortality patients for acute revascularization in order to protect their statistics. One solution to this dilemma that we worked out when I was in Massachusetts (which also has mandatory statewide reporting) was to develop a completely separate category of SOS ("shock or salvage") patients who are reported separately and do not contribute to one's benchmarks. Maybe New York should pick up on this.
# 4 of 6
January 29, 2008 06:36 (EST)
Melissa Walton-Shirley
Good for you guys!
David,
Thanks for clarifying. I'm still mad though. I certainly always want to rant accurately, so I appreciate your information.
The patients wind up on the short end of the stick anyway it seems. Sound like you guys came up with a superb plan.

Melissa
# 5 of 6
January 29, 2008 07:38 (EST)
David Cohen
A good rant
Melissa-
Far be it from me to get in the way of a good rant. Carry on!
# 6 of 6
January 30, 2008 12:58 (EST)
Melissa Walton-Shirley
done I think
Thanks David,
I guess I'm done now unless of course new information comes to light!
Hope you have a wonderful rant free day!!
Melissa

You have to be logged in to add a comment to this article
Login
Username 
Password 
  Forgot your password?
 
Remember me on this computer
 
Join theheart.org community
Five reasons to become a member of the most trusted source of cardiology news:
1Be part of the conversation in our blogs and discussion forum
2Share your thoughts on our news or educational programs
3Receive exclusive newsletters related to your field of interest
4Access unique continuous medical education content
5See and read what leaders have to say about cardiology today
It is free and it only takes five minutes to join!
 
button
Previews
Featured CME
Inside: Acute Coronary Syndromes
Acute Coronary Syndromes
Jun 22, 2009 00:07 EDT
Early-ACS, HORIZONS-AMI, On-TIME 2... How do you use GP IIb/IIIa inhibitors in contemporary practice? Given the continued uncertainty regarding the optimal duration of dual antiplatelet therapy, what do you do for AF patients on warfarin who need stents? Answer our 3 short polling questions and learn your peers' responses.
Acute Coronary Syndromes
Jun 12, 2009 15:10 EDT
Studies suggest that major bleeding is associated with a 5-fold increase in the risk for death among ACS patients. Join our expert panel: Profs. Hamm, Kristensen, and Spaulding as they discuss treatment options and strategies to reduce bleeding in STEMI patients.